European Bourses : An Update
Archives of “September 27, 2020” day
rssAn Update : FAANG ,Microsoft ,TSLA ,ZM ,NIKE ,VISA : Anirudh Sethi
To read more enter password and Unlock more engaging content
Forex Update : US Dollar Index ,Euro Index ,AUD ,JPY ,GBP ,CAD ,NZD ,INR -Anirudh Sethi
To read more enter password and Unlock more engaging content
An Update :GOLD ,SILVER ,PALLADIUM ,PLATINUM NICKEL ,COPPER ,ZINC ,LEAD :Anirudh Sethi
To read more enter password and Unlock more engaging content
Surging U.S. Corporate Cash Points Toward Higher Payouts
Euro Banks: Dead Men Walking
These charts are hard to take. Have you ever seen such dead money investments?Here’s to hoping that if Jamie Dimon becomes Secretary of Treasury in a Biden Administration — a huge stretch given the rising power of the Democratic left — he never allows negative interest rate policy NIRP (yes, we get it, it’s theoretically the Fed’s job).Look what NIRP has wrought, or should we say rot in Europe.
Dollar Positioning (updated).
Despite the Dollar’s sharp rally this week, Futures traders SOLD another $2.5 Billion – now the biggest Short Dollar position in 9 years. If this USD rally continues, a lot of traders look headed for an expensive lesson in risk management.
The lower the price of a stock, the higher the operating cost.
“Investors have finally realized that stocks cannot go up forever and are shedding their positions. The QQQ ETF suffered its biggest fund outflow since October 2000.”
J&J Coronavirus vaccine candidate – induced immune response, showed acceptable safety profile
Johnson & Johnson’s experimental Covid-19 vaccine phase 1/2 trial findings have provided some encouragement.
Reports the Wall Street Journal:
- induced immune responses in most people who received the shot
- displayed an acceptable safety profile
Now for some caveats. These are from a small early-stage trial. They are interim, posted on online preprint server medRxiv. The report is not yet peer-reviewed, not yet published in medical journals.
J&J have said that they’ll now carry on with a larger late-stage study of up to 60,000 people that will provide more definitive evidence.
The link above has more, its the Journal so it may be gated. CNN has an ungated report at this link if you prefer.
- The vaccine — called Ad26.COV2.S — uses the same technology used for Johnson & Johnson’s Ebola, Zika, HIV and RSV vaccines.
